SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lakatos L.)
 

Sökning: WFRF:(Lakatos L.) > (2015-2019) > Natural disease cou...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00012083naa a2201513 4500
001oai:prod.swepub.kib.ki.se:141202547
003SwePub
008240911s2019 | |||||||||||000 ||eng|
009oai:DiVA.org:oru-64714
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1412025472 URI
024a https://doi.org/10.1136/gutjnl-2017-3155682 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-647142 URI
040 a (SwePub)kid (SwePub)oru
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Burisch, Ju Department of Gastroenterology, Nordsjællands Hospital, University of Copenhagen, Frederikssund, Denmark4 aut
2451 0a Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
264 c 2018-01-23
264 1b BMJ,c 2019
500 a Funding Agencies:Kirsten og Freddy Johansens Fond  Nordsjaellands Hospital Forskningsrad
520 a The Epi-IBD cohort is a prospective population-based inception cohort of unselected patients with inflammatory bowel disease from 29 European centres covering a background population of almost 10 million people. The aim of this study was to assess the 5-year outcome and disease course of patients with Crohn’s disease (CD).DesignPatients were followed up prospectively from the time of diagnosis, including collection of their clinical data, demographics, disease activity, medical therapy, surgery, cancers and deaths. Associations between outcomes and multiple covariates were analysed by Cox regression analysis.ResultsIn total, 488 patients were included in the study. During follow-up, 107 (22%) patients received surgery, while 176 (36%) patients were hospitalised because of CD. A total of 49 (14%) patients diagnosed with non-stricturing, non-penetrating disease progressed to either stricturing and/or penetrating disease. These rates did not differ between patients from Western and Eastern Europe. However, significant geographic differences were noted regarding treatment: more patients in Western Europe received biological therapy (33%) and immunomodulators (66%) than did those in Eastern Europe (14% and 54%, respectively, P<0.01), while more Eastern European patients received 5-aminosalicylates (90% vs 56%, P<0.05). Treatment with immunomodulators reduced the risk of surgery (HR: 0.4, 95% CI 0.2 to 0.6) and hospitalisation (HR: 0.3, 95% CI 0.2 to 0.5).ConclusionDespite patients being treated early and frequently with immunomodulators and biological therapy in Western Europe, 5-year outcomes including surgery and phenotype progression in this cohort were comparable across Western and Eastern Europe. Differences in treatment strategies between Western and Eastern European centres did not affect the disease course. Treatment with immunomodulators reduced the risk of surgery and hospitalisation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng
653 a Crohn’s disease
700a Kiudelis, Gu Institute for Digestive Research, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania4 aut
700a Kupcinskas, Lu Institute for Digestive Research, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania; Department of Gastroenterology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania4 aut
700a Kievit, HALu Department of Medicine, Herning Central Hospital, Herning, Denmark4 aut
700a Andersen, KWu Medical Department, Regional Hospital of Viborg, Viborg, Denmark4 aut
700a Andersen, Vu Medical Department, Regional Hospital of Viborg, Viborg, Denmark; Focused research unit for Molecular Diagnostic and Clinical Research (MOK), IRS-Center Sonderjylland, Hospital of Southern Jutland, Aabenraa, Denmark4 aut
700a Salupere, Ru Division of Gastroenterology, Tartu University Hospital, University of Tartyu, Tartu, Estonia4 aut
700a Pedersen, Nu Gastroenterology Department, Slagelse Hospital, Slagelse, Denmark4 aut
700a Kjeldsen, Ju Gastroenterology Department, Odense University Hospital, Odense, Denmark4 aut
700a D'Inca, Ru Department of Surgical, Oncological and Gastroenterological Sciences, Azienda, University of Padua, Padova, Italy,IBD Clinical and Research Centre (ISCARE), Prague, Czech Republic4 aut
700a Valpiani, Du U.O. Gastroenterologia ed Endoscopia digestiva, Hospital Morgagni Pierantoni, Forlì, Italy4 aut
700a Schwartz, Du Department of Gastroenterology and Hepatology, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel4 aut
700a Odes, Su Department of Gastroenterology and Hepatology, Soroka Medical Center, Ben Gurion University of the Negev, Beer Sheva, Israel4 aut
700a Olsen, Ju Medical Department, The National Hospital of the Faroe Islands, Thorshavn, Denmark4 aut
700a Nielsen, KRu Medical Department, The National Hospital of the Faroe Islands, Thorshavn, Denmark4 aut
700a Vegh, Zu 1st Department of Medicine, Semmelweis University, Budapest, Hungary4 aut
700a Lakatos, PLu 1st Department of Medicine, Semmelweis University, Budapest, Hungary; Division of Gastroenterology, McGill University Health Center, Montreal, Canada4 aut
700a Toca, Au Department of Gastroenterology, State University of Medicine and Pharmacy of the Republic of Moldova, Chisinau, Republic of Moldova4 aut
700a Turcan, Su Department of Gastroenterology, State University of Medicine and Pharmacy of the Republic of Moldova, Chisinau, Republic of Moldova4 aut
700a Katsanos, KHu Department of Gastroenterology, University Hospital of Ioannina, Ioannina, Greece4 aut
700a Christodoulou, DKu Department of Gastroenterology, University Hospital of Ioannina, Ioannina, Greece4 aut
700a Fumery, Mu Gastroenterology Unit, Epimad Registry, Centre hospitalier universitaire (CHU) Amiens Sud, Amiens University Hospital, Amiens, France4 aut
700a Gower-Rousseau, Cu Public Health, Epidemiology and Economic Health, Registre Epimad, Lille Hospital, Lille University, Lille, France; Lille Inflammation Research International Center (LIRIC), Lille University, Lille, France4 aut
700a Zammit, SCu Division of Gastroenterology, Mater Dei Hospital, Msida, Malta,IBD Unit, Hull and East Yorkshire NHS Trust, Hull, UK4 aut
700a Ellul, Pu Division of Gastroenterology, Mater Dei Hospital, Msida, Malta4 aut
700a Eriksson, Carl,d 1981-u Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden4 aut0 (Swepub:oru)clen
700a Halfvarson, Jonas,d 1970-u Örebro universitet,Institutionen för medicinska vetenskaper,Department of Gastroenterology, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden4 aut0 (Swepub:oru)jshn
700a Magro, FJu Department of Gastroenterology, Centro Hospitalar de São João EPE, Porto, Portugal; Department of Biomedicine, Institute of Pharmacology, Faculty of Medicine, Porto University, Porto, Portugal4 aut
700a Duricova, D4 aut
700a Bortlik, Mu IBD Clinical and Research Centre (ISCARE), Prague, Czech Republic; Institute of Pharmacology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic4 aut
700a Fernandez, Au Department of Gastroenterology, Hospital POVISA, Vigo, Spain4 aut
700a Hernandez, Vu Department of Gastroenterology, Hospital Alvaro Cunqueiro. Instituto Investigación Sanitaria Galicia Sur. EOXI de Vigo, Vigo, Spain4 aut
700a Myers, Su IBD Unit, Hull and East Yorkshire NHS Trust, Hull, UK4 aut
700a Sebastian, S4 aut
700a Oksanen, Pu Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland; University of Tampere, Tampere, Finland4 aut
700a Collin, Pu University of Tampere, Tampere, Finland4 aut
700a Goldis, Au Clinic of Gastroenterology, University of Medicine 'Victor Babes', Timisoara, Romania4 aut
700a Misra, Ru IBD Department, Imperial College London, London, UK4 aut
700a Arebi, Nu IBD Department, Imperial College London, London, UK4 aut
700a Kaimakliotis, IPu Nicosia private practice, Nicosia, Cyprus4 aut
700a Nikuina, Iu Department of Gastroenterology, Moscow Regional Research Clinical Institute, Moscow, Russian Federation4 aut
700a Belousova, Eu Department of Gastroenterology, Moscow Regional Research Clinical Institute, Moscow, Russian Federation4 aut
700a Brinar, Mu Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia4 aut
700a Cukovic-Cavka, Su Division of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb, Croatia4 aut
700a Langholz, Eu Department of Gastroenterology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark4 aut
700a Munkholm, Pu Department of Gastroenterology, Nordsjællands Hospital, University of Copenhagen, Frederikssund, Denmark4 aut
700a Niewiadomski, O4 aut
700a Bell, S4 aut
700a Turk, N4 aut
700a Cukovic-Cavka, S4 aut
700a Kaimakliotis, I4 aut
700a Nicolaou, A4 aut
700a Duricova, D4 aut
700a Lukas, M4 aut
700a Bortlik, M4 aut
700a Shonova, O4 aut
700a Burisch, J4 aut
700a Munkholm, P4 aut
700a Langholz, E4 aut
700a Blichfeldt, B4 aut
700a Marker, D4 aut
700a Carlsen, K4 aut
700a Weimers, P4 aut
700a Pedersen, N4 aut
700a Kjeldsen, J4 aut
700a Aalykke, C4 aut
700a Dahlerup, JF4 aut
700a Kudsk, K4 aut
700a Andersen, V4 aut
700a Vind, I4 aut
700a Thorsgaard, N4 aut
700a Salupere, R4 aut
700a Olsen, J4 aut
700a Nielsen, KR4 aut
700a Oksanen, P4 aut
700a Collin, P4 aut
700a Katsanos, KH4 aut
700a Christodoulou, DK4 aut
700a Skamnelos, A4 aut
700a Politis, D4 aut
700a Ladefoged, K4 aut
700a Lakatos, PL4 aut
700a Vegh, Z4 aut
700a Lakatos, L4 aut
700a Demenyi, P4 aut
700a Kramli, SN4 aut
700a O'Morain, C4 aut
700a Dal Piaz, G4 aut
700a Santini, A4 aut
700a Girardin, G4 aut
700a D'Inca, R4 aut
700a Schwartz, D4 aut
700a Odes, S4 aut
700a Kupcinskas, L4 aut
700a Jonaitis, L4 aut
700a Kiudelis, G4 aut
700a Valantiene, I4 aut
710a Department of Gastroenterology, Nordsjællands Hospital, University of Copenhagen, Frederikssund, Denmarkb Institute for Digestive Research, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania4 org
773t Gutd : BMJg 68:3, s. 423-433q 68:3<423-433x 1468-3288x 0017-5749
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141202547
8564 8u https://doi.org/10.1136/gutjnl-2017-315568
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-64714

Hitta via bibliotek

  • Gut (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy